About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 378 record(s)
Req # A-2021-000604
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-075631-61.Organization: Health Canada
September 2021
Req # A-2021-000622
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075079-338.Organization: Health Canada
September 2021
Req # A-2021-000634
Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE. Report number: E2B_03420918.Organization: Health Canada
September 2021
Req # A-2021-000648
Adverse Drug Reaction (ADR) for CANDESARTAN. Report number: E2B_03406743.Organization: Health Canada
September 2021
Req # A-2021-000649
Adverse Drug Reaction (ADR) for CLONAZEPAM. Report number: E2B_03468382.Organization: Health Canada
September 2021
Req # A-2021-000650
Adverse Reaction Reports (AERs) for CYCLOPHOSPHAMIDE. Report numbers: 918864, 918869, 918929.Organization: Health Canada
September 2021
Req # A-2021-000662
Adverse Reaction Reports (AERs) for ZOPICLONE. Report numbers: E2B_03428005, E2B_03472178, E2B_03468297.Organization: Health Canada
September 2021
Req # A-2021-000681
Adverse Reaction Reports (AERs) for ARIPIPRAZOLE. Report numbers: E2B_03459143, E2B_03459508, E2B_03459562.Organization: Health Canada
September 2021
Req # A-2021-000682
Adverse Reaction Reports (AERs) for ALFUZOSIN HYDROCHLORIDE. Report numbers: E2B_03460157, E2B_03480472.Organization: Health Canada
September 2021
Req # A-2021-000710
All the Covid Vaccine Contracts between the Canadian Government and the following drug companies: Pfizer, Moderna and Astrazeneca for 2019, 2020, 2021, 2022, 2023, 2024.Organization: Health Canada
September 2021